Results from the first randomized clinical trial testing hydroxychloroquine for the post-exposure prevention of COVID-19 that were published in the New England Journal of Medicine determined that hydroxychloroquine was not able to prevent the development of COVID-19 any better than a placebo.
Other News
With students, many staff, faculty, and researchers already on campus, and others making plans to return this fall, I want to acknowledge…
I’m young and healthy, why should I get vaccinated? In the United States, we have a long history of helping each other. If a river is…
We’re a month away from the start of classes for the 2021/22 Academic Year and I believe we are all looking forward to seeing colleagues…